Two-Point Dynamic Observation of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus
-
- Jingami, Naoto
- Department of Neurology, Kyoto University Graduate School of Medicine・Department of Human Health Sciences, Kyoto University Graduate School of Medicine
-
- Uemura, Kengo
- Department of Neurology, Kyoto University Graduate School of Medicine・Department of Neurology, Yurinkai Ishiki Hospital, Kagoshima
-
- Asada-Utsugi, Megumi
- Department of Neurology, Kyoto University Graduate School of Medicine・Department of Human Health Sciences, Kyoto University Graduate School of Medicine
-
- Kuzuya, Akira
- Department of Neurology, Kyoto University Graduate School of Medicine・Department of Human Health Sciences, Kyoto University Graduate School of Medicine
-
- Yamada, Shigeki
- Normal Pressure Hydrocephalus Center, Rakuwakai Otowa Hospital, Kyoto
-
- Ishikawa, Masatsune
- Normal Pressure Hydrocephalus Center, Rakuwakai Otowa Hospital, Kyoto
-
- Kawahara, Takashi
- Normal Pressure Hydrocephalus Center, Jifukai Atsuchi Neurosurgical Hospital, Kagoshima
-
- Iwasaki, Takuya
- Normal Pressure Hydrocephalus Center, Jifukai Atsuchi Neurosurgical Hospital, Kagoshima
-
- Atsuchi, Masamichi
- Normal Pressure Hydrocephalus Center, Jifukai Atsuchi Neurosurgical Hospital, Kagoshima
-
- Takahashi, Ryosuke
- Department of Neurology, Kyoto University Graduate School of Medicine
-
- Kinoshita, Ayae
- Department of Human Health Sciences, Kyoto University Graduate School of Medicine
Description
Background: Extensive research into cerebrospinal fluid (CSF) biomarkers was performed in patients with idiopathic normal pressure hydrocephalus (iNPH). Most prior research into CSF biomarkers has been one-point observation. Objective: To investigate dynamic changes in CSF biomarkers during routine tap test in iNPH patients. Methods: We analyzed CSF concentrations of tau, amyloid-β (Aβ) 42 and 40, and leucine rich α-2-glycoprotein (LRG) in 88 consecutive potential iNPH patients who received a tap test. We collected two-point lumbar CSF separately at the first 1 ml (First Drip (FD)) and at the last 1 ml (Last Drip (LD)) during the tap test and 9 patients who went on to receive ventriculo-peritoneal shunt surgery each provided 1 ml of ventricular CSF (VCSF). Results: Tau concentrations were significantly elevated in LD and VCSF compared to FD (LD/FD = 1.22, p = 0.003, VCSF/FD = 2.76, p = 0.02). Conversely, Aβ₄₂ (LD/FD = 0.80, p < 0.001, VCSF/FD = 0.38, p = 0.03) and LRG (LD/FD = 0.74, p < 0.001, VCSF/FD = 0.09, p = 0.002) concentrations were significantly reduced in LD and VCSF compared to FD. Gait responses to the tap test and changes in cognitive function in response to shunt were closely associated with concentrations of tau (p = 0.02) and LRG (p = 0.04), respectively. Conclusions: Dynamic changes were different among the measured CSF biomarkers, suggesting that LD of CSF as sampled during the tap test reflects an aspect of VCSF contributing to the pathophysiology of iNPH and could be used to predict shunt effectiveness.
Journal
-
- Journal of Alzheimer's disease
-
Journal of Alzheimer's disease 72 (1), 271-277, 2019-10-29
IOS Press
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1050845763825383552
-
- NII Article ID
- 120006767911
-
- ISSN
- 13872877
- 18758908
-
- HANDLE
- 2433/244815
-
- PubMed
- 31561378
-
- Text Lang
- en
-
- Article Type
- journal article
-
- Data Source
-
- IRDB
- Crossref
- CiNii Articles
- KAKEN
- OpenAIRE